Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 08 03 2024
revised: 22 04 2024
accepted: 24 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: epublish

Résumé

Protein kinases are essential regulators of cell function and represent one of the largest and most diverse protein families. They are particularly influential in signal transduction and coordinating complex processes like the cell cycle. Out of the 518 human protein kinases identified, 478 are part of a single superfamily sharing catalytic domains that are related in sequence. The dysregulation of protein kinases due to certain mutations has been associated with various diseases, including cancer. Although most of the protein kinase inhibitors identified as type I or type II primarily target the ATP-binding pockets of kinases, the structural and sequential resemblances among these pockets pose a significant challenge for selective inhibition. Therefore, targeting allosteric pockets that are beside highly conserved ATP pockets has emerged as a promising strategy to prevail current limitations, such as poor selectivity and drug resistance. In this article, we compared the binding pockets of various protein kinases for which allosteric (type III) inhibitors have already been developed. Additionally, understanding the structure and shape of existing ligands could aid in identifying key interaction sites within the allosteric pockets of kinases. This comprehensive review aims to facilitate the design of more effective and selective allosteric inhibitors.

Identifiants

pubmed: 38731943
pii: ijms25094725
doi: 10.3390/ijms25094725
pii:
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Protein Kinases EC 2.7.-
Ligands 0
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2020R1A6A1A03042854 (Center for Proteinopathy), NRF-2021R1A2C2007159 (J.-M.Hah)

Auteurs

Swapnil P Bhujbal (SP)

College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Republic of Korea.

Joonhong Jun (J)

College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Republic of Korea.

Haebeen Park (H)

College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Republic of Korea.

Jihyun Moon (J)

College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Republic of Korea.

Kyungbae Min (K)

College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Republic of Korea.

Jung-Mi Hah (JM)

College of Pharmacy, Hanyang University, Ansan 426-791, Republic of Korea.
Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 426-791, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH